To our knowledge the following list presents the analysts publishing material commenting on Abcam. We provide this list for your convenience only and do not endorse or express any opinion on the reports these analysts publish.
| Company | Analyst |
|---|---|
| Berenberg | Charles Weston |
| Investec | Andrew Whitney |
| JP Morgan Cazenove | David Adlington |
| Numis Securities | Stefan Hamill |
| Panmure Gordon & Co | Julie Simmonds |
| Peel Hunt | Tom Burt |
| RBC Securities | Nick Keher |
| Stifel | Olivia Manser |
Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.
Read more +As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.
Read more +Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts
Read more +We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.
Read more +
